ARYA Sciences Acquisition Corp IV (ARYD)
NASDAQ: ARYD · IEX Real-Time Price · USD
10.90
-0.01 (-0.09%)
At close: Dec 29, 2023, 4:00 PM
10.88
-0.02 (-0.18%)
After-hours: Dec 29, 2023, 4:00 PM EST
| Market Cap | 86.41M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 1.44M |
| Shares Out | 7.93M |
| EPS (ttm) | 0.09 |
| PE Ratio | 121.11 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 32,306 |
| Open | 10.88 |
| Previous Close | 10.91 |
| Day's Range | 10.85 - 10.90 |
| 52-Week Range | 10.10 - 10.95 |
| Beta | -0.01 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About ARYD
ARYA Sciences Acquisition Corp IV does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York. [Read more]
Industry Shell Companies
Sector Financials
IPO Date Feb 26, 2021
Country United States
Stock Exchange NASDAQ
Ticker Symbol ARYD
Financial Performance
Financial StatementsNews
ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus' Gene Therapy Business Due to Market Conditions
NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp IV (NASDAQ: ARYD) (“ARYA IV”), a publicly traded special purpose acquisition company sponsored by Perceptive Advisors announc...
2 years ago - GlobeNewsWire